On Air Now

Current Show

NDSU Bison Football   2:30 PM - 5:30 PM

Hear all the Bison football games on KFGO

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 790 AM Fargo-Moorhead

Weather

Current Conditions(Fargo,ND 58103)

More Weather »
67° Feels Like: 67°
Wind: NNW 25 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 51°

Tomorrow

Mostly Sunny 68°

Sun Night

Clear 47°

Alerts

Merck's ragweed pollen allergy drug gets U.S. approval

(Reuters) - The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis. (http://r.reuters.com/nyg68v)

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Grastek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

(This story corrects fourth paragraph to say Grastek, not Ragwitek, will compete with Stallergenes' drug)

(Reporting by Shailesh Kuber; Editing by Sriraj Kalluvila)

Comments